Antibody therapeutics are a large and rapidly expanding drug class providing major health
benefits. We provide a snapshot of current antibody therapeutics including their formats …

Aerosolization of immunotherapies poses incredible potential for manipulating the local
mucosal-specific microenvironment, engaging specialized pulmonary cellular defenders …

The development of vaccines has always been an essential task worldwide since vaccines
are regarded as powerful weapons in protecting the global population. Although the vast …

The ongoing threat of COVID-19 has highlighted the need for effective prophylaxis and
convenient therapies, especially for outpatient settings. We have previously developed …

Passive delivery of antibodies to mucosal sites may be a valuable adjunct to COVID-19
vaccination to prevent infection, treat viral carriage, or block transmission. Neutralizing …

The COVID-19 pandemic represents a global challenge that has impacted and is expected
to continue to impact the lives and health of people across the world for the foreseeable …

Inhaled medicines continue to be an essential part of treatment for respiratory diseases such
as asthma, chronic obstructive pulmonary disease, and cystic fibrosis. In addition, inhalation …

Introduction Respiratory diseases represent a worldwide health issue. The recent Sars-CoV-
2 pandemic, the burden of lung cancer, and inflammatory respiratory diseases urged the …

Background Most biopharmaceuticals are developed in liquid dosage forms that are less
stable than solid forms. To ensure the stability of biopharmaceuticals, it is critical to use an …

Introduction Monoclonal antibodies (mAbs) should be administered by inhalation rather than
parenterally to improve their efficiency in lung diseases. However, the pulmonary …